Literature DB >> 26001076

Enhancing neurogenesis and angiogenesis with target delivery of stromal cell derived factor-1α using a dual ionic pH-sensitive copolymer.

Dong Hee Kim1, Young Kyu Seo2, Thavasyappan Thambi2, Gyeong Joon Moon3, Jung Pyo Son1, Guangri Li2, Jae Hyung Park2, Jung Hee Lee4, Hyeon Ho Kim5, Doo Sung Lee6, Oh Young Bang7.   

Abstract

In this study, we hypothesized that the delivery of molecules that regulate the microenvironment after a cerebral infarction can influence regeneration potential after a stroke. Stromal cell-derived factor-1α (SDF-1α) is a chemoattractant molecule that plays a pivotal role in recruiting endothelial progenitor cells (EPCs) to the infarct region after stroke. Increased SDF-1α expression leads to increased EPCs homing at the infarct region and induces neurogenesis, angiogenesis, neuroprotection, and stem cell homing. Thus, we evaluated the effects of targeted delivery of SDF-1α using a pH-sensitive polymer poly (urethane amino sulfamethazine) (PUASM), a synthetic macromolecule with potential for targeted drug delivery in acidic conditions, to enhance therapeutic neurogenesis and angiogenesis in a rat model of permanent middle cerebral artery occlusion. A dual ionic pH-sensitive copolymer PUASM-based random copolymer was designed and synthesized for the controlled release of SDF-1α in stroke. Owing to the unique characteristics of PUASM, it exhibited a dual ionic pH-sensitive property in an aqueous solution. At pH 8.5, the copolymer exhibited a negative charge and was water soluble. Interestingly, when the pH decreased to 7.4, PUASM could form a micelle and encapsulate protein effectively via the ionic interaction between a negatively charged polymer and a positively charged protein. At pH 5.5, the ionization of tertiary amines led to the disassembly of the micellar structure and released the protein rapidly. Then, we investigated the effect of systemic administration of SDF-1α-loaded pH-sensitive polymeric micelles in a stroke induced rat model. An enzyme-linked immunosorbent assay showed increased expression of SDF-1α in the ischemic region, indicating that the pH-sensitive micelles effectively delivered SDF-1α into the ischemic region. In order to observe the biodistribution of SDF-1α in the ischemic region, it was labeled with the near-infrared dye, Cy5.5. Optical imaging showed that the Cy5.5 signal increased in the infarct region 24 h after administration. Immunohistochemistry data showed that targeted delivery of SDF-1α enhanced neurogenesis and angiogenesis, but did not influence cell survival or inflammation. These observations suggest that SDF-1α-loaded pH-sensitive polymeric micelles can be used as pH-triggered targeting agents and can effectively modify the microenvironment to increase innate neurorestorative processes.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Ischemic stroke; Neurogenesis; Polymeric micelle; SDF-1α; pH-sensitive

Mesh:

Substances:

Year:  2015        PMID: 26001076     DOI: 10.1016/j.biomaterials.2015.05.025

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  20 in total

Review 1.  Let's get small (and smaller): Combining zebrafish and nanomedicine to advance neuroregenerative therapeutics.

Authors:  David T White; Meera T Saxena; Jeff S Mumm
Journal:  Adv Drug Deliv Rev       Date:  2019-02-12       Impact factor: 15.470

Review 2.  Hydrogel Scaffolds: Towards Restitution of Ischemic Stroke-Injured Brain.

Authors:  Aswathi Gopalakrishnan; Sahadev A Shankarappa; G K Rajanikant
Journal:  Transl Stroke Res       Date:  2018-08-27       Impact factor: 6.829

3.  Stroke Induces Mesenchymal Stem Cell Migration to Infarcted Brain Areas Via CXCR4 and C-Met Signaling.

Authors:  Oh Young Bang; Gyeong Joon Moon; Dong Hee Kim; Ji Hyun Lee; Sooyoon Kim; Jeong Pyo Son; Yeon Hee Cho; Won Hyuk Chang; Yun-Hee Kim
Journal:  Transl Stroke Res       Date:  2017-05-25       Impact factor: 6.829

Review 4.  Biomaterials for recruiting and activating endogenous stem cells in situ tissue regeneration.

Authors:  Ingrid Safina; Mildred C Embree
Journal:  Acta Biomater       Date:  2022-03-12       Impact factor: 10.633

5.  Application of Mesenchymal Stem Cell-Derived Extracellular Vesicles for Stroke: Biodistribution and MicroRNA Study.

Authors:  Gyeong Joon Moon; Ji Hee Sung; Dong Hee Kim; Eun Hee Kim; Yeon Hee Cho; Jeong Pyo Son; Jae Min Cha; Oh Young Bang
Journal:  Transl Stroke Res       Date:  2018-10-19       Impact factor: 6.829

Review 6.  Using biomaterials to modulate chemotactic signaling for central nervous system repair.

Authors:  Kassondra Hickey; Sarah E Stabenfeldt
Journal:  Biomed Mater       Date:  2018-04-27       Impact factor: 3.715

7.  Stem cell homing, tracking and therapeutic efficiency evaluation for stroke treatment using nanoparticles: A systematic review.

Authors:  Mariana Penteado Nucci; Igor Salerno Filgueiras; João Matias Ferreira; Fernando Anselmo de Oliveira; Leopoldo Penteado Nucci; Javier Bustamante Mamani; Gabriel Nery Albuquerque Rego; Lionel Fernel Gamarra
Journal:  World J Stem Cells       Date:  2020-05-26       Impact factor: 5.326

8.  Poly(amino carbonate urethane)-based biodegradable, temperature and pH-sensitive injectable hydrogels for sustained human growth hormone delivery.

Authors:  V H Giang Phan; Thavasyappan Thambi; Huu Thuy Trang Duong; Doo Sung Lee
Journal:  Sci Rep       Date:  2016-07-20       Impact factor: 4.379

9.  Cerebral Hemodynamics and Vascular Reactivity in Mild and Severe Ischemic Rodent Middle Cerebral Artery Occlusion Stroke Models.

Authors:  Jeongeun Sim; Areum Jo; Bok-Man Kang; Sohee Lee; Oh Young Bang; Chaejeong Heo; Gil-Ja Jhon; Youngmi Lee; Minah Suh
Journal:  Exp Neurobiol       Date:  2016-06-22       Impact factor: 3.261

Review 10.  Biomaterial Applications in Cell-Based Therapy in Experimental Stroke.

Authors:  Ligia S B Boisserand; Tomonobu Kodama; Jérémie Papassin; Rachel Auzely; Anaïck Moisan; Claire Rome; Olivier Detante
Journal:  Stem Cells Int       Date:  2016-05-04       Impact factor: 5.131

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.